Exhibit H — Case 1:21-md-02989-CMA (Document 577-4)
Summary
Exhibit H (Document 577-4) in Case 1:21-md-02989-CMA, entered on the FLSD docket 06/16/2023, is a press release dated Oct 3, 2008 in which The Rosen Law Firm announced that it filed a class action lawsuit on behalf of all purchasers of Medicis Pharmaceutical Corp. stock from October 30, 2003 through September 24, 2008. The release states that the action is pending in the United States District Court for the District of Arizona as case no. 2:08-cv-1821 and that the complaint charges that Medicis and certain of its officers violated Sections 10(b) and 20(a) of the Exchange Act. It states that on September 24, 2008 Medicis announced that it intends to restate its financial statements for the accounting periods beginning July 1, 2003 and ending June 30, 2008.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
- Issuer
- Source documents
- Document type
- Gov.Uscourts.Flsd.590042.577.4
- Case
- Gov.Uscourts.Flsd.590042.577.4
Cite this document
“Exhibit H — Case 1:21-md-02989-CMA (Document 577-4).”
Original at archive.org. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/gov-uscourts-flsd-590042-577-4/
, SHA-256 ce555e3da474bc00534ce215f3861bbb99388dc761d57a207f7b538e6c2010d1.Full text
Text recognized from a scanned document; may contain errors.
Case 1:21-md-02989-CMA Document 577-4 Entered on FLSD Docket 06/16/2023 Page 1 of 3
EXHIBIT H
Press Release Source: Rosen Law Firm P.A.
The Rosen Law Firm Files Securities Class Action Charging
Medicis Pharmaceutical Corp. With Violations of the Federal
Securities Laws -- MRX
Friday October 3, 8:00 pm ET
NEW YORK, NY--(MARKET WIRE)--Oct 3, 2008 -- The Rosen Law Firm today announced that it has filed a
class action lawsuit on behalf of all purchasers of Medicis Pharmaceutical Corp. ("Medicis") (MRX - News)
stock during the period from October 30, 2003 through September 24, 2008 (the "Class Period").
To join the Medicis class action, go to the website at http: //rosenlegal.com or call Laurence Rosen, Esq. or
Phillip Kim, Esq. toll-free at 866-767-3653 or email mailto:lrosen@rosenlegal.comlrosen@rosenlegal.com
or mailto:pkim@rosenlegal.compkim@rosenlegal.com for information on the class action.
The action is pending in the United States District Court for the District of Arizona as case no. 2:08-cv-1821.
You can obtain a copy of the complaint from the clerk of court or you may contact counsel for plaintiffs
Laurence Rosen, Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU
ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN
ABSENT CLASS MEMBER. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The complaint charges that Medicis and certain of its officers violated Sections 10(b) and 20(a) of the
Exchange Act by issuing materially inaccurate financial statements to the investing public. On September 24,
2008, Medicis announced that it intends to restate its financial statements for each of the accounting periods
beginning July 1, 2003 and ending June 30, 2008, and that investors can no longer rely on these financial
statements. The restatement is necessary because Medicis applied an improper accounting method in
determining reserves for sales returns during the Class Period. News of the pending restatement caused
Medicis’ stock price to fall significantly, damaging investors.
A class action lawsuit has already been filed on behalf of Medicis shareholders. If you wish to serve as lead
plaintiff, you must move the Court no later than December 2, 2008. If you wish to join the litigation or to discuss
your rights or interests regarding this class action, please contact plaintiff's counsel, Laurence Rosen, Esq. or
Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at Irosen@rosenlegal.com or
pkim@rosenlegal.com.
The Rosen Law Firm represents investors throughout the world, concentrating its practice in securities class
actions and shareholder derivative litigation.
Contact:
Contact:
Laurence Rosen, Esq.
Email Contact
Phillip Kim, Esq.
Email Contact
The Rosen Law Firm P.A.
350 Sth Avenue, Suite 5508
Tel: (212) 686-1060
Weekends Tel: (917) 797-4425
File and source
- File
- gov.uscourts.flsd.590042.577.4.pdf
- Size
- 182,258 bytes
- SHA-256
- ce555e3da474bc00534ce215f3861bbb99388dc761d57a207f7b538e6c2010d1
- Original
- archive.org